College of Medicine and Health Research Conference
Dr Simon Woodworth, Lead Investigator delivering a keynote lecture on the LINDA-FAMILIA project at the College of Medicine and Health Research Conference in UCC in September 2025
Dr Simon Woodworth, Lead Investigator delivering a keynote lecture on the LINDA-FAMILIA project at the College of Medicine and Health Research Conference in UCC in September 2025
A new digital health project has been awarded âŹ4.9 million funding to help protect mothers and children in East Africa by using smart digital tools to fight infectious diseases and save lives.
A University College Cork (UCC) led project, LINDA-FAMILIA, meaning âProtect the Familyâ in Swahili, has been funded under the Horizon Europe Programme to revolutionise maternal and child health in East Africa.
Led by the INFANT Research Centre at UCC, the initiative will deploy scalable, interoperable digital health systems to track infectious diseases and support health services in pregnancy, postpartum, and childhood care.
Transforming Maternal and Child Health Through Digital Innovation
LINDA-FAMILIA will implement an open source, integrated digital health information system to replace paper-based records in four priority regions: Addis Ababa â Ethiopia, Eastern Province â Rwanda, Kilimanjaro Region â Tanzania, Lango Sub-region â Uganda.
Using the free and open source DHIS2 platform, the worldâs largest health information system, the project will integrate 11 World Health Organisation (WHO) recommended Digital Health Interventions (DHIs) to create country specific eRegistries. These systems will capture individual level health data on infectious diseases and vaccinations, enabling improved clinical care, disease surveillance, and public health research, at lower cost than existing systems. DHIS2 is especially suited to the LINDA-FAMILIA project as it is designed for use in low resources settings where internet coverage is unreliable. It makes use of technology freely available in sub-Saharan Africa.
The initiative brings together 11 global partner consortiums from Ireland, Tanzania, Ethiopia, Rwanda, Uganda, Norway and the UK and is coordinated by UCC, under the leadership of Ali Khashan, Professor in Perinatal Epidemiology, School of Public Health and INFANT Research Centre at UCC.
âThis project addresses a fundamental gap in health systems: access to reliable, timely data,â said Prof. Ali Khashan, Project Lead. âBy combining global scientific expertise with deep local knowledge, weâre building sustainable digital tools that not only improve health data systems but also support clinical decision-making in maternal and child health.â
Why this work matters: A Region Burdened by Preventable Deaths
While many countries, face challenges with outdated and fragmented digital health infrastructures, the LINDA-FAMILIA research team chose to focus on East Africa because of the urgent public health need and a strong regional momentum toward digital transformation.
Sub Saharan Africa continues to face disproportionately high rates of maternal and child mortality. In 2020 alone, the region accounted for 70% of maternal deaths worldwide, with infectious diseases such as HIV, malaria, hepatitis B, syphilis, TB, and sepsis as leading contributors. These are preventable conditions – but health systems are hindered by fragmented, siloed, and paper-based data systems.
LINDA-FAMILIA aims to correct that by enabling real time data use for evidence-based care, empowering both healthcare providers and policy makers with the information they need to deliver timely interventions:
âWe see firsthand the urgent need for stronger health data systems across East Africa. By replacing fragmented, paper-based records with a scalable and integrated digital system, we can dramatically improve how care is delivered and ultimately, save lives,â says Prof. Blandina Mmbaga, Project Scientific Coordinator and Director Kilimanjaro Clinical Research Institute.
Dr Simon Woodworth, the projectâs Information Systems Lead said: “The LINDA-FAMILIA system is designed not only to capture reliable data but also to empower local health workers – and in turn pregnant women – with the information they need to make safer choices. By strengthening digital systems and making them accessible and relevant at community level, we are creating solutions that will remain practical and sustainable long after the project ends.”
Built on a Legacy of Innovation
The project builds on the ULTRA Project, a collaboration between UCC, Kilimanjaro Clinical Research Institute (KCRI), and the Global Pregnancy Collaboration (CoLab). ULTRA successfully developed and implemented an eRegistry system in maternal and child health units across Tanzania, transforming how health data is captured and used. The ULTRA project was funded by an IRC Coalesce grant.
This work also honours the memory of the late Professor Christopher Redman (1941â2024) A great inspirer, mentor, scientist, and collaborator who made giant clinical steps forward in the field of maternal and newborn health and who contributed significantly to the early stages of this work. His inspiration and dedication live on in this project.
By building institutional capacity and ensuring integration with national health systems, the LINDA-FAMILIA project supports long-term sustainability. It aims to serve as a model for how digital health systems can contribute to universal health coverage, improved epidemic preparedness, and equitable healthcare across low-resource settings:
âThis is impressive and as one of the partners we are looking forward to a successful implementation which will enable us to draw best practices for scale up,â says Dr Grace Magembe, Chief Medical Officer, Tanzania.
In the News:
The INFANT Research Centre at University College Cork (UCC) hosted a Family Fun Science Fair on Saturday, 9th August 2025 at Fota Wildlife Parkâs Education, Conservation and Research Centre (ECRC) which welcomed over 530 visitors across the day including children with CP, their families, carers, and the general public attending Fota Wildlife Park on the day.
The event was filled with fun, discovery, creativity, and education, with a special focus on Cerebral Palsy (CP) research from the ELEVATE Research Programme.
ELEVATE, led by INFANT at UCC is a five-year research programme that aims to improve the prevention, detection and treatment of early brain injury and cerebral palsy (CP) in Ireland. CP is the most common lifelong physical disability, it is a group of disorders that affect a personâs ability to move and maintain balance and posture. It is caused by abnormal development or damage to parts of the brain. The severity of CP and the extent of the symptoms depend on both the extent of the damage or abnormalities and where they occur in the brain.
ELEVATE has been funded under the Research Ireland Strategic Partnership Programme, with co-funding partner The Cerebral Palsy Foundation (CPF). INFANT, UCC is partnered with RCSI University of Medicine and Health Sciences, Trinity College Dublin (TCD) and all the tertiary-level maternity hospitals in Ireland.
The science fair gave families the opportunity to meet researchers, connect with others in the CP community, and learn more about the work being done through the ELEVATE Programme.

A Day Where Science Meets Exploration
From the moment the doors opened at 12pm, the ECRC was buzzing with excitement. Families took part in hands-on demonstrations and inclusive interactive exhibits, including:
đ§Ź CP Research & Awareness Zone â Showcasing ELEVATE research studies, sharing progress to date, and looking ahead to whatâs next. Visitors enjoyed bite-sized talks from project leads explaining the background to the research and an overview of the programme. They also heard a powerful perspective from a parent of a child with CP, who is an active member of INFANTâs CP-focused Parent Advisory Group (CP PAG), highlighting the importance of lived experience in shaping research to improve outcomes.
đž Meet the Wild Scientists â Researchers involved in ELEVATE from UCC, TCD, and RCSI chatted to families about their work. The team included project and work package leads, PhD students, nurses, neurophysiologists, data scientists, engineers, physiotherapists, research fellows, research support staff, and others!
đ¤ AI & the Brain â Our neurophysiologist demonstrated brain monitoring by analysing his own brain activity live on a portable EEG machine, highlighting our work in newborn brain monitoring. Visitors also enjoyed an interactive AI game where both they and a computer guessed animals based on various clues.
đ Vision & Eye Monitoring Activities â Interactive games illustrated different visual experiences and how they can affect daily life.
đ¨ Creative Learning Activities â Arts, crafts designed for all ages and areas to unwind took place in the chill out zone!
đ§Ş The Bloody Detective Workshop â Mini-sessions exploring whatâs in your blood, why itâs important, and how it helps doctors make key medical decisions.
đ§ą Bricks 4 Kidz Workshop â Bricks 4 Kidz hosted a hands-on STEM workshop using LEGOÂŽ, Technic, and Robotics to inspire building and problem-solving skills.



We were delighted to be joined by some of our collaborators including In4kids (HRBâs national childrenâs clinical trial network), Cork University Foundation (sharing giving opportunities to support research at UCC), and The Cerebral Palsy Foundation (co-funder of the ELEVATE Programme).This science fair forms part of ELEVATEâs Education and Public Engagement Programme.

âEvents like this let us share our research in a way thatâs fun, interactive, inclusive and accessible. Itâs also a way for families to see the faces behind the research and for us to hear directly from the CP community. Engaging families throughout the research process has always been integral to our work at the INFANT Research Centre, and these events shows how important it really is.â
Prof. Geraldine Boylan, INFANT UCC Director



For more information on the ELEVATE programme, visit: https://www.infantcentre.ie/research/elevate/

Photography by Joleen Cronin
On this International Youth Day, In4kids, Irelandâs national paediatric clinical trials network, hosted at the INFANT Research Centre in University College Cork,  is shining a light on the essential role that young people play in shaping the future of healthcare. Observed globally on August 12th, the day celebrates young peopleâs engagement as a driving force behind more inclusive, equitable, and forward-thinking communitiesâand, in the case of In4kids, more effective and patient-centred research.
A core part of this commitment is the National Young Personsâ Advisory Group (YPAG), an initiative co-developed by In4kids and the Childrenâs Health Ireland Clinical Research Centre (CHI-CRC), with support from the Health Research Board. The YPAG empowers young people aged 12â18 to contribute directly to the planning and design of paediatric clinical trials, research studies and healthcare innovation projects from across Ireland.
Through the YPAG, young people collaborate with clinicians and researchers to offer feedback that helps make studies more relevant, and reflective of young patientsâ real-world experiences. Their insights help guide research that is not only scientifically robust but also shaped by those it aims to serve.
Elevating Young Peopleâs Participation in Research
Since its launch in August 2024, the YPAG has grown into a vibrant and diverse group of over 30 members from all over the country. The group has met in person in Dublin and Cork and continues to hold regular online meetings, ensuring that young people from different regions and backgrounds have flexible, meaningful opportunities to engage.
YPAG members have contributed to several research projects already, in collaboration with hospitals, and academic partners nationwide. Whether reviewing study materials, advising on recruitment strategies, improving methodology or helping to shape project priorities, the group is actively improving how paediatric research is performed and implemented in Ireland and making it more relevant for children and young people.
Children must have the same access to high quality, evidence-based medication and health care services as adults
This principle lies at the heart of In4kids activities and the YPAGâs continued achievements and growth will ensure this becomes standard across the healthcare landscape. By involving young people at every stage of the research journey, In4kids alongside CHI-CRC, is building a more responsive clinical research environment where the needs and voices of children and adolescents are placed front and centre.
As we mark International Youth Day, In4kids celebrates the passion, insight, and leadership of these young contributors. Their involvement is helping to ensure that paediatric research in Ireland is more inclusive, impactful, and attuned to the needs of its youngest patients.
To learn more about the National YPAG or how to get involved, please contact in4kids@ucc.ie
Overview of the ENIGMA Study
Children diagnosed with Autism often experience mental health challenges such as anxiety, low mood, and depression but itâs not clear what triggers these challenges. The ENIGMA research study aims to understand how various factors like environment, diet, stress, and activity levels affect the mental health of autistic children. By examining these factors, the researchers hope to develop strategies and alert systems to support children and their families better when triggers occur.
Aim of the study:
âENIGMAâ is an acronym for âEnvironmental influence on mental illness via modifications of genomes and metabolomes in adolescents with Autismâ
The aim of the study is to observe the daily lives of up to 400 autistic children aged 11-15 years across Europe. This study is funded by Horizon Europe, which is the research funding body of the European Union.
Who is it for?Â
Exclusion Criteria
What’s Involved:
Baseline Visit
There will be five study visits (including the baseline visit) over a six-month period and may include:Â Â
What will happen to the results of this study?
Results of this research study may be published in medical journals and presented at scientific meetings. Following completion of the study the anonymised data collected will be made available to researchers in an open access repository to aid future research work. However, your child will never be identified individually during these presentations/in this repository and will not be revealed in any reports or publications.
Where can I get more information?
If you have any further questions regarding this study, please contact the ENIGMA Research Team at ENIGMA@ucc.ie or (086) 143-6020
Conclusion
The study aims to deepen the researchers understanding of the factors influencing the mental health of autistic children. By involving families, conducting assessments and completing questionnaires, the study seeks to develop effective support systems for these children in the future.
Friday, 25th July, 2025: The Department of Foreign Affairs and Trade, Department of Rural and Community Development and the Gaeltacht, and the Embassy of the United States of America in Dublin are pleased to announce 18 Fulbright Irish Awardees for 2025-2026. Recipients were presented with Awards at a ceremony in the U.S. Embassy last night.
Founded in 1946, the Fulbright bilateral exchange programme has served to strengthen international relations by facilitating academic and cultural exchanges globally for over 79 years. The Fulbright Program in Ireland has awarded grants to more than 2,500 Irish and American citizens since 1957, contributing to enduring Ireland-U.S. relations and a global culture of understanding.
Fulbright alumni include 44 current or former heads of state, 62 Nobel Laureates, 90 Pulitzer Prize-winners, and 82 MacArthur Foundation Fellows. Each year, talented and remarkable candidates from across Ireland are selected to research, study and teach with leading experts at top institutions across the U.S. in disciplines ranging from business, law, health and technology to culture, heritage, the arts, and the Irish language.
From August 2025 to August 2026, Fulbright Irish Scholars, Students and Professionals will attend institutions ranging from the University of Texas Southwestern Medical Center, Georgia Institute of Technology, and the University of Kansas to the School of the Art Institute of Chicago, the Maxine Greene Institute, and the University of Colorado Boulder. Awardees will research, innovate and collaborate across a diverse range of fields including multimedia arts, philosophy, medicine, agriculture, education, art history, AI technology in medicine, AI technology in education, visual arts, and health.
Fulbright Foreign Language Teaching Assistants (FLTAs) will teach the Irish language and attend Irish language Immersion weekends at the University of Wisconsin-Milwaukee, College of Our Lady of the Elms, University of Montana, and the University of Notre Dame.
Awardees serve as cultural ambassadors during their time in the U.S. and share their knowledge, ideas and experience upon their return, creating lasting impacts for society. Fulbright awardees, inspired by the mission, ethos and legacy of the Fulbright Program of creating a global culture of mutual understanding, continue the important work of strengthening ties between the U.S. and Ireland and advancing much needed empathy in todayâs increasingly divided world.
The Fulbright Irish Awards will open on 28th August 2025. Interested candidates should visit www.fulbright.ie for more information.
Speaking at the awards ceremony, U.S. Ambassador to Ireland, Edward S. Walsh, saidâŚ
âThe Fulbright Program plays a crucial role in strengthening ties between the United States and Ireland. Through educational and cultural exchanges, Fulbright awardees work toward fostering mutual understanding and finding solutions to global issues, ensuring that our extraordinary transatlantic relationship continues to flourish. I congratulate this yearâs awardees on their success.â
TĂĄnaiste, Minister for Foreign Affairs and Trade, and Minister for Defence, Simon Harris T.D., saidâŚ
âI warmly congratulate the Fulbright Irish Awardees for 2025-2026. The Fulbright Program â spanning 14 presidential administrations â has been an important initiative in sustaining the unique and special relationship that Ireland and the United States share. At the dawn of the age of artificial intelligence, there is still no substitution for the personal engagement, which sustains our deep and rich people-to-people connections. As such, Fulbright Awardees serve as cultural ambassadors for Ireland in the United States, sharing their knowledge, expertise and learnings upon return. I am proud that my Government has supported Fulbright to maintain and strengthen ties between the U.S. and Ireland and build on our transatlantic academic and cultural connections. I want to wish the Fulbright Irish Awardees 2025-2026 every success as they embark on this exciting journey.â
Speaking at the awards ceremony, Chair of the Fulbright Commission Ireland Board, Professor Paul Donnelly, saidâŚ
âOn behalf of the Fulbright Commission Ireland Board, I am delighted to congratulate the 18 Fulbright Irish Awardees on their success. At a time of global change and uncertainty, the mission, values and legacy of the Fulbright Program of leadership, empathy, understanding, and collaboration endure, embodied by a new cohort of excellent Fulbright awardees embarking on academic and cultural exchanges in the United States. We take pride in their achievement and wish the awardees a rich and rewarding experience.â
Speaking at the awards ceremony, Executive Director of the Fulbright Commission in Ireland, Dr Dara FitzGerald, saidâŚ
âAs Executive Director of the Fulbright Commission in Ireland, it is gratifying to see a new cohort of thriving Fulbright Irish Awardees embark on Fulbright awards to the United States. Awardees join a growing global network of Fulbright alumni, friends and colleagues who have achieved accolades across all disciplines. While the Fulbright Program is synonymous with cutting edge research, innovation, teaching and academic excellence, it is equally known for its important role in strengthening international relations and fostering mutual understanding through cultural exchange. As Senator J. Fulbright said, âThe Fulbright Program aims to bring a little more knowledge, a little more reason, and a little more compassion into world affairs.â
I would like to highlight the ongoing and sterling support of our partners, the Irish Governmentâs Department of Foreign Affairs and Trade and the Department of Rural and Community Development and the Gaeltacht, and the U.S. Department of State through the U.S. Embassy in Dublin.
We are deeply grateful to our Irish award sponsors and partners: Research Ireland, the Health Research Board, the Environmental Protection Agency, Geological Survey Ireland, National University of Ireland, Teagasc, the Creative Ireland Programme, the Heritage Council and notable U.S. Institutions such as the Exploratorium, the Smithsonian, the Harry Ransom Center, Florida Polytechnic University, the University of Southern California, the University of Notre Dame and the University of Pennsylvania Carey Law School; and Irish institutions such as University College Cork, Technological University of the Shannon, Technological University of Dublin, AMBER Research Centre, University College Dublin, Dublin City University, RCSI University of Medicine and Health Sciences, University of Galway, Maynooth University, University of Limerick and the Kemmy Business School, Atlantic Technological University, and the Dublin Institute of Advanced Studies.â
There is 1 Fulbright UCC Awardee this year – from INFANT Research Centre:
Dr Lisa Kiely MD is a Dermatology Specialist Registrar and an Irish Clinical Academic Training (ICAT) Fellow at the INFANT Research Centre, University College Cork. She holds an honours BSc in Physiology from the University of Galway, a postgraduate medical degree from the University of Limerick, and a Masterâs in Clinical Education from Queenâs University Belfast. Currently pursuing a PhD, her research focuses on using advanced imaging techniques to improve detection and monitoring of disease activity in morphea, a rare inflammatory skin condition. Her work aims to improve how this condition is monitored and managed in clinical practice. As a Fulbright Irish Student Awardee, Lisa will travel to the University of Texas Southwestern Medical Center in Dallas, Texas, where she will collaborate with Professor Heidi Jacobe, a global leader in morphea research. Lisa is excited at the opportunity to foster long-term transatlantic collaboration in morphea research.
Today, on World Brain Day, weâre proud to shine a light on the work we do at the INFANT Research Centre at University College Cork (UCC).
The theme for World Brain Day 2025 is âBrain Health for All Ages,â continuing global efforts to promote brain health as a lifelong priority.
The day aims to raise awareness about brain health and promote neurological research. Established by the World Federation of Neurology, World Brain Day highlights the importance of brain health and the ongoing need for research, education, and innovation to combat neurological disorders. It also serves as an inspiration for young minds to explore the complexities of the human brain and contribute to advancements in neuroscience.
The INFANT Research Centre is a hub of world-leading research and innovation, dedicated to improving outcomes during pregnancy, the newborn period, and early childhood.
A core focus of our research is the newborn brain, understanding it, protecting it, and ensuring the best possible start for every child.
We have achieved a number of milestones in Brain Health over the years and continue to do so, here are some of the highlights:
âĄď¸ Read more: https://www.infantcentre.ie/2024/12/03/lancet-publication/
INFANT conducts a number of research projects prioritising newborn brain health, one particular project is called ELEVATE, a five-year research programme which is focused on the prevention, early detection, and treatment of brain injury and cerebral palsy in infants, particularly during the critical window of neuroplasticity (up to 2 years of age). INFANT is leading this programme in collaboration with Trinity College Dublin(TCD), Royal College of Surgeons in Ireland (RCSI), Irelandâs tertiary-level maternity hospitals. Itâs funded under a Strategic Partnership Programme by Research Ireland and the Cerebral Palsy Foundation (CPF).
ELEVATE aims to establish Ireland as a world-leading hub for CP research and innovation.
Together, we are leveraging cutting-edge technologies and multidisciplinary collaboration to transform the landscape of CP research and care.
The goal: to improve outcomes and quality of life for children with CP, their families and carers in Ireland and globally.
âĄď¸ Learn more about the programme: https://www.infantcentre.ie/research/elevate/
âĄď¸ Read an Interview with Prof Deirdre Murray, the CPF Chair of Early Brain Injury and Cerebral Palsy: (10) Cerebral Palsy Foundation Chair in Early Brain Injury and Cerebral Palsy: Professor Deirdre Murray, One Year On – 6th Oct 2024 | LinkedIn
đĄ Why It Matters
This World Brain Day, we recognise our incredible researchers, clinicians, and collaborators who are working every day to ensure every child has the best possible start in life.
Through science, innovation, and collaboration, we continue to advance the field of brain health, starting at the very beginning.
A new study by researchers at University College Cork (UCC), Ireland found that 60% of pregnant women had suboptimal iodine status, highlighting a need for increased nutritional awareness to support maternal and child health.
Published recently in the European Journal of Nutrition, the IMPROvED study evaluated iodine levels in over 1,500 women who were pregnant with their first baby at Cork University Maternity Hospital. The research was led by Dr Ăine Hennessy from the Irish Centre for Maternal and Child Health Research (INFANT) and the Cork Centre for Vitamin D & Nutrition Research at the School of Food and Nutritional Sciences.
Key Findings:
Why This Matters
Iodine is essential for thyroid hormone production, which supports a babyâs brain development during pregnancy. A womanâs iodine requirement increases by 50% during pregnancy, making adequate intake from our diet essential. Our bodies cannot make iodine, so we must get it from our diet. Deficiency can lead to adverse outcomes, including impaired neurodevelopment in children.
âIodine deficiency is one of the most common micronutrient deficiencies worldwide, there is little public awareness of the important role that iodine plays in brain development during pregnancyâ said Dr Ăine Hennessy, lead researcher.
âOur findings are particularly concerning as most women in the study were considered healthy and low risk and two thirds reported taking pregnancy supplements containing iodine. This suggests that additional public health measures may need to be addressedâ
Public Health Implications
Ireland does not currently have a policy for salt iodisation or iodine food fortification. While National Clinical Practice Guidelines recommend prioritising iodine intake from foods, and supplement use where intake from food is not adequate, the level of awareness of the importance of iodine during pregnancy is low. This research reveals a need for policy review and nutrition education for women of childbearing age.
Dr Hennessy advises: âWomen planning a pregnancy should ensure adequate iodine intake through diet â including two or more servings of milk or yoghurt daily and eating white fish once a week is recommended by the HSE. For those following vegan or predominantly plant-based diets, itâs important to choose iodine fortified alternatives. We do not recommend kelp or seaweed supplements, as they can contain very high levels of iodine that can cause issues for the thyroidâ
This study was a secondary analysis of the IMPROvED Study, funded by a Science Foundation Ireland (Research Ireland) Starting Investigator Research Grant to lead investigator, Dr Ăine Hennessy.
These findings serve as an important first step in informing and guiding public health nutrition policies.
ENDS.
Notes to the Editor:
About INFANT Research Centre, UCC
We are thrilled to share that Prof Geraldine Boylan, Director of INFANT & UCC Futures Children, has been awarded the UCC Medical School Medal 2024.
Prof Paula OâLeary, Dean of the School of Medicine at UCC, congratulated  Prof Boylan on receiving the award, âWe are hugely proud of Prof Boylanâs achievements and her amazing journey. Her success and leadership at the interface of neuroscience, bioengineering, physiology and neonatology is not only deeply respected by her peers but also serves a powerful inspiration to the next generation of clinical scientists and doctorsâ.
Her work continues to make a real and lasting impact – improving care and outcomes for many children and their families. CergenX, an INFANT Centre spin out co-founded by Prof Boylan, is translating research into clinical practice with the Wave deviceâan AI-powered innovation in neonatal neuroprotective care that is revolutionising the assessment of newborn brain function.
Huge congratulations to Prof Boylan on this well-deserved recognition.
The IMAGINE Study is a nationwide research study led by University College Cork.
Researchers at the INFANT Research Centre, University College Cork and University of Galway are looking for people of all ages who have been diagnosed with morphea to take part.
What is the IMAGINE Study?Â
âIMAGINEâ stands for âImaging Morphea: Advancements for DiaGnosis and INtensive Evaluationâ.
Morphea is a rare skin condition that can cause permanent scarring. Because it often appears subtle at first, it can be hard to diagnose and can be very difficult to monitor. It is important for doctors to know when the disease is active, so they can treat it early and help prevent long-term damage.
In order to better track activity, we are performing a research study to look at the blood vessels and inflammation in morphea skin compared to unaffected skin. We are inviting people of all ages with morphea to attend for an assessment and specialised imaging.
The study is being led by a team from:
Who is it for?Â
We are inviting adults and children living in Ireland who have been diagnosed with morphea by a consultant dermatologist or rheumatologist.
What do I need to do?
The study will take place in the South Infirmary Victoria University Hospital, Cork University Hospital, Mayo University Hospital, University Hospital Galway and Tallaght University Hospital or their related clinical research facilities. You will be invited to attend the centre where you are currently a patient or the nearest centre to you.
During your visit:
Why is this study being done?
We hope this study will help us to:
We also hope to raise awareness about morphea in Ireland and encourage more research in this area.
What are the benefits and risks of participating in this study?
Taking part in this study will provide valuable data on this rare condition. The results may help us to detect disease activity more accurately which may improve our understanding and impact the future treatment of this condition. Participating in this study will allow us to learn more about the Irish morphea patients and contribute to further research in this field. You may benefit from this, or it may be that people in the future may benefit.
We are not aware of any risks of taking part in this study. As this study is an observational study, we are collecting data only with no intervention. There will be no changes to your medical care and no changes to your medication. There are no risks to your health. All data collected will be strictly confidential.
What is the time commitment?
What will happen to the results of this study?
The results of this study will be published in academic journals and presented at scientific meetings. You will never be identified individually during these presentations or any reports or publications. To ensure confidentiality, the data generated during this study is coded with a unique Study ID Number that will be allocated once you (or your child) is recruited to the study.
University College Cork (UCC) is the studyâs Sponsor and will act as the data controller for this study. Any personal data which you provide to the University will be treated with the highest standards of security and confidentiality, in accordance with Irish and European Data Protection legislation.
Where can I get more information?
If you have any further questions regarding this study, please contact Dr Lisa Kiely:Â lisa.kiely@ucc.ie
Interested in taking part in the study?
Fill out the enquiry form and a member of the research team will contact you: https://forms.cloud.microsoft/e/zC04NGseKcÂ